5 things to watch on the ASX 200 on Tuesday

On Monday, the S&P/ASX 200 Index (ASX: XJO) started the week with a heavy decline. The benchmark index fell 1% to 8,778.6 points.

Will the market be able to bounce back from this on Tuesday? Here are five things to watch:

ASX 200 expected to rebound

The Australian share market looks set to rebound on Tuesday following a decent start to the week in Europe. According to the latest SPI futures, the ASX 200 is poised to open the day 81 points or 0.95% higher. In late trade on Wall Street, the Dow Jones is up 1.1%, the S&P 500 is up 0.65%, and the Nasdaq is up 0.7%.

Oil prices sink

It could be a tough session for ASX 200 energy shares such as Karoon Energy Ltd (ASX: KAR) and Santos Ltd (ASX: STO) after oil prices sank overnight. According to Bloomberg, the WTI crude oil price is down 4.9% to US$62.03 a barrel and the Brent crude oil price is down 4.4% to US$66.29 a barrel. Traders were selling oil in response to easing US-Iran tensions.

ResMed upgraded

The team at Bell Potter thinks that ResMed Inc. (ASX: RMD) shares are good value at current levels. The broker has upgraded the sleep disorder treatment company’s shares to a buy rating with a $47.73 target price. It said: “2Q beat across the board, with double-digit revenue and earnings growth, further gross margin expansion and solid cash generation. Sleep and respiratory sales were strong in both regions, with above-market growth in the Americas and ROW returning to market growth, while SaaS beat expectations, but remained subdued by residential care headwinds. Operating leverage improved again, with gross margin gains from manufacturing and logistics efficiencies, and FY26 guidance tightened to 62-63% (from 61-63%), reinforcing confidence in ongoing margin progression.”

Gold price falls again

ASX 200 gold shares including Evolution Mining Ltd (ASX: EVN) and Ramelius Resources Ltd (ASX: RMS) could have another poor session on Tuesday after the gold price fell again overnight. According to CNBC, the gold futures price is down 1.85% to US$4,670 an ounce. The precious metal has been sold off since Donald Trump nominated his next US Federal Reserve chief.

Hold CSL shares

CSL Ltd (ASX: CSL) shares are a hold according to analysts at Bell Potter. This morning, the broker has reaffirmed its hold rating and $195.00 price target on the biotech giant’s shares. It said: “At 17x PE, CSL trades at a significant discount to its historical average and below domestic peers, however we consider this to be justified considering the low organic growth outlook, earnings growth below peers, and blows to credibility following the Seqirus de-merger pivot and recent downgrades to long-term guidance.”

The post 5 things to watch on the ASX 200 on Tuesday appeared first on The Motley Fool Australia.

More reading

• Here are the top 10 ASX 200 shares today
• Leading brokers name 3 ASX shares to buy today
• Buy, hold, sell: BHP, CSL, and Endeavour shares
• Corporate Travel Management announces major leadership changes
• GrainCorp shares: FY26 earnings guidance forecasts lower profits

Motley Fool contributor James Mickleboro has positions in CSL and ResMed. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL and ResMed. The Motley Fool Australia has positions in and has recommended ResMed. The Motley Fool Australia has recommended CSL. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.